ERBB2 and breast cancer: HER2+ BC is rare among BRCA1/2 mutation carriers; a low frequency (2.1% to 10%) of HER2+ status and BRCA1 PVs/LPVs carriers and a slightly higher rate (6.8% to 13%) in those with germinal mutations in BRCA2 have been found [67].